6 Papers
M. Sherr is an academic researcher from Johns Hopkins University School of Medicine. The author has contributed to research in topics: Huntington's disease & Medicine. The author has an hindex of 6, co-authored 6 publications.
Chat about Author
Papers
Frontal lobe volume in patients with Huntington's disease
Elizabeth H. Aylward,N. B. Anderson,Frederick W. Bylsma,M. V. Wagster,Patrick E. Barta,M. Sherr,J. Feeney,A. Davis,Adam Rosenblatt,Godfrey D. Pearlson,Christopher A. Ross +10 more
TL;DR: It is concluded that cognitive impairment and symptom severity are associated with frontal lobe atrophy, but this association is not specific to the frontal lobes.
183
Familial influence on age of onset among siblings with Huntington disease
Adam Rosenblatt,Ryan R. Brinkman,Kung-Yee Liang,E. Almqvist,Russell L. Margolis,Chiung Yu Huang,M. Sherr,M.L. Franz,M. H. Abbott,Michael R. Hayden,Christopher A. Ross +10 more
TL;DR: It is found that CAG number alone accounted for 65%-71% of the variance in age of onset and the siblingship an individual belonged to accounted for 11%-19% of additional variance, adding to the previous evidence that there are familial modifiers of the age of dawn, independent of the CAGNumber.
122
A controlled trial of idebenone in Huntington's disease
N G Ranen,Carol E. Peyser,Joseph T. Coyle,Frederick W. Bylsma,M. Sherr,Leslie Day,Marshal F. Folstein,Jason Brandt,Christopher A. Ross,Susan E. Folstein +9 more
TL;DR: Sample size calculations based on progression of the ADL and QNE in this study group revealed that a larger study group is necessary to detect any differences less than an almost complete halting of the disease.
99
Does CAG repeat number predict the rate of pathological changes in Huntington's disease?
Adam Rosenblatt,Russell L. Margolis,Mark W. Becher,Elizabeth Aylward,Elizabeth Aylward,M.L. Franz,M. Sherr,M. H. Abbott,Kung-Yee Liang,Christopher A. Ross +9 more
TL;DR: Although Okuizumi and his associates and the authors' own group obtained the same result in Japanese subjects with PSP, an examination of the methodologies used in the two studies raises concerns with broader implications for the field of genetics in general.
14
Rate of caudate atrophy in presymptomatic and symptomatic stages of Huntington's disease
Elizabeth Aylward,Elizabeth Aylward,Ann Marie Codori,Adam Rosenblatt,M. Sherr,Jason Brandt,Oscar C. Stine,Patrick E. Barta,Godfrey D. Pearlson,Christopher A. Ross +9 more
TL;DR: It is concluded that change in caudate volume may be a useful outcome measure for assessing treatment effectiveness in both presymptomatic and symptomatic subjects.